Abstract
Non-invasive prenatal diagnosis (NIPD) is a rapidly advancing approach that allows diagnostic testing based on analysis of cell free DNA in maternal plasma. This study aimed to explore the views of health professionals regarding the use of NIPD for BRCA1/2 mutations. Qualitative semi-structured interviews were conducted with eight participants. Whilst participants viewed NIPD in general as a positive step forward in prenatal testing, they were cautious about its use for BRCA testing. Significant ethical concerns emerged regarding testing prenatally for an adult onset condition, that is not fully penetrant, and the possibility of abrogating the rights of the future child to genetic autonomy. Nevertheless, participants did identify some situations whereby the test might be beneficial, such as for individuals with very negative and traumatic personal experiences of cancer desiring reassurance or wanting to prevent passing on the condition. NIPD was also seen as having benefits over invasive testing and pre-implantation genetic diagnosis, the only other options currently available to test prenatally for this condition. Exploring the views of a wider range of clinical specialties as well as patients at risk of hereditary breast cancer would be beneficial.
Similar content being viewed by others
References
American College of Obstetricians and Gynecologists Committee on Genetics. (2012). Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstetrics and Gynecology, 120, 1532–1534.
Barrett, A. N., McDonnell, T. C., Chan, K. C., & Chitty, L. S. (2012). Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clinical Chemistry, 58, 1026–1032.
Bianchi, D. W., Platt, L. D., Goldberg, J. D., Abuhamad, A. Z., Sehnert, A. J., & Rava, R. P. (2012). Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology, 119, 890–901.
Borry, P., Fryns, J. P., Schotsmans, P., & Dierickx, K. (2006a). Carrier testing in minors: a systematic review of guidelines and position papers. European Journal of Human Genetics, 14, 133–138.
Borry, P., Stultiens, L., Nys, H., Cassiman, J. J., & Dierickx, K. (2006b). Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clinical Genetics, 70, 374–381.
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3, 77–101.
Chitty, L. S., Griffin, D. R., Meaney, C., Barrett, A., Khalil, A., Pajkrt, E., et al. (2011). New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma. Ultrasound in Obstetrics and Gynecology, 37, 283–289.
de Jong, A., Dondorp, W. J., de Die-Smulders, C. E., Frints, S. G., & de Wert, G. M. (2010). Non-invasive prenatal testing: ethical issues explored. European Journal of Human Genetics, 18, 272–277.
Derks-Smeets, I. A., Gietel-Habets, J. J., Tibben, A., Tjan-Heijnen, V. C., Meijer-Hoogeveen, M., Geraedts, J. P., et al. (2014). Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer. Human Reproduction, 29, 1103–1112.
Donnelly, L. S., Watson, M., Moynihan, C., Bancroft, E., Evans, D. G., Eeles, R., et al. (2013). Reproductive decision-making in young female carriers of a BRCA mutation. Human Reproduction, 28, 1006–1012.
Finning, K. M., & Chitty, L. S. (2008). Non-invasive fetal sex determination: impact on clinical practice. Seminars in Fetal and Neonatal Medicine, 13, 69–75.
Fortuny, D., Balmana, J., Grana, B., Torres, A., Ramon y Cajal, T., Darder, E., et al. (2009). Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort. Human Reproduction, 24, 1000–1006.
Fossey, E., Harvey, C., McDermott, F., & Davidson, L. (2002). Understanding and evaluating qualitative research. The Australian and New Zealand Journal of Psychiatry, 36, 717–732.
Hill, M., Karunaratna, M., Lewis, C., Forya, F., & Chitty, L. (2013). Views and preferences for the implementation of non-invasive prenatal diagnosis for single gene disorders from health professionals in the United Kingdom. American Journal of Medical Genetics Part A, 161A, 1612–1618.
Illanes, S., Denbow, M., Kailasam, C., Finning, K., & Soothill, P. W. (2007). Early detection of cell-free fetal DNA in maternal plasma. Early Human Development, 83, 563–566.
Julian-Reynier, C., Fabre, R., Coupier, I., Stoppa-Lyonnet, D., Lasset, C., Caron, O., et al. (2012). BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis. Genetics in Medicine, 14, 527–534.
Kelly, S. E., & Farrimond, H. R. (2012). Non-invasive prenatal genetic testing: a study of public attitudes. Public Health Genomics, 15, 73–81.
Lewis, C., Hill, M., Skirton, H., & Chitty, L. (2012). Non-invasive prenatal diagnosis for fetal sex determination – benefits and disadvantages from the service users’ perspective. European Journal of Human Genetics, 20, 1127–1133.
Lewis, C., Silcock, C., & Chitty, L. S. (2013). Non-invasive prenatal testing for Down’s syndrome – pregnant women’s views and likely uptake. Public Health Genomics, 16, 223–232.
Lewis, C., Hill, M., & Chitty, L. (2014a). Non-invasive prenatal diagnosis for single gene disorders: experience of patients. Clinical Genetics, 85, 336–342.
Lewis, C., Hill, M., Silcock, C., Daley, R., & Chitty, L. S. (2014b). Non-invasive prenatal testing for trisomy 21: a cross sectional survey of service users’ views and likely uptake. BJOG, 121, 582–594.
Lo, Y. M., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., et al. (1997). Presence of fetal DNA in maternal plasma and serum. Lancet, 350, 485–487.
McAllister, M., Payne, K., Macleod, R., Nicholls, S., Dian, D., & Davies, L. (2008). Patient empowerment in clinical genetics services. Journal of Health Psychology, 13, 895–905.
Nelson, H. D., Huffman, L. H., Fu, R., & Harris, E. L. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 143, 362–379.
Ormondroyd, E., Donnelly, L., Moynihan, C., Savona, C., Bancroft, E., Evans, D. G., et al. (2012). Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis. European Journal of Human Genetics, 20, 4–10.
Palomaki, G. E., Deciu, C., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., et al. (2012). DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genetics in Medicine, 14, 296–305.
Skirton, H., Goldsmith, L., Jackson, L., & Tibben, A. (2013). Quality in genetic counselling for presymptomatic testing--clinical guidelines for practice across the range of genetic conditions. European Journal of Human Genetics, 21, 256–260.
Tabor, A., & Alfirevic, Z. (2010). Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagnosis and Therapy, 27, 1–7.
Tischler, R., Hudgins, L., Blumenfeld, Y. J., Greely, H. T., & Ormond, K. E. (2011). Noninvasive prenatal diagnosis: pregnant women’s interest and expected uptake. Prenatal Diagnosis, 31, 1292–1299.
Tsui, N. B., Kadir, R. A., Chan, K. C., Chi, C., Mellars, G., Tuddenham, E. G., et al. (2011). Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood, 117, 3684–3691.
van den Heuvel, A., Chitty, L., Dormandy, E., Newson, A., Deans, Z., Attwood, S., et al. (2009). Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Education and Counseling, 78, 24–28.
Wagner, T. M., & Ahner, R. (1998). Prenatal testing for late-onset diseases such as mutations in the breast cancer gene 1 (BRCA1). Just a choice or a step in the wrong direction? Human Reproduction, 13, 1125–1126.
Willig, C. (2008). Introducing qualitative research methods in psychology qualitative research design (pp. 15–32). Maidenhead: McGraw Hill.
Yi, H., Hallowell, N., Griffiths, S., & Yeung Leung, T. (2013). Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong. PLoS One, 8, e81794.
Acknowledgments
The authors would like to acknowledge and thank all the health professionals who took part in this study and the reviewers of this paper for their insightful comments.
Conflict of Interest
The authors Jade Bennett, Lyn Chitty and Celine Lewis declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study. No animal studies were carried out by the authors for this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bennett, J., Chitty, L. & Lewis, C. Non-invasive Prenatal Diagnosis for BRCA Mutations – a Qualitative Pilot Study of Health Professionals’ Views. J Genet Counsel 25, 198–207 (2016). https://doi.org/10.1007/s10897-015-9858-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-015-9858-0